HONG KONG, Feb. 1, 2018 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801) (the "Company"),a leading integrated healthcare enterprise in China, announces today the TDR repurchase period is closed on January 31, 2018, regarding the proposed voluntary delisting of the Taiwan
Details have been published by the Company in accordance with the Rules Governing the Listing of Securities on the Stock Exchange of Hong Kong Limited and posted on the Company's website as follows: http://www.goldenmeditech.com/eng/ir/announcements.php?year=2018
About Golden Meditech Holdings Limited (SEHK stock code: 00801)
Golden Meditech (www.goldenmeditech.com) is a leading integrated-healthcare enterprise in China. It is a first-mover in China, having established its dominant positions in several markets including the medical devices market and the hospital management market in the healthcare industry, thanks to its strengths in innovation and market expertise and the ability to capture emerging market opportunities. Going forward, Golden Meditech will continue to pursue a leading position in China's healthcare industry both through organic growth and strategic expansion.
View original content:http://www.prnewswire.com/news-releases/golden-meditech-announces-close-of-repurchase-of-tdr-for-the-delisting-of-tdr-on-twse-300591818.html
SOURCE Golden Meditech Holdings Limited
Subscribe to our Free Newsletters!
Osteolysis refers to breaking down of bone tissue. Bone loss occurs due to resorption of bone by ...
Patisiran injection, recently approved by FDA to treat polyneuropathy, a disease that causes ...
Dysgraphia or disorder of written expression is a childhood learning disorder marked by poor ...View All